
Recently I was in a meeting talking about grants, and needing to find grant money to fund a follow-up project to the one we were currently working on. Except that’s not really how the discussion played out. Essentially, it became about identifying where the money’s at – e.g. breast cancer, diabetes etc. and how we can make the follow-up project suit the agenda of these funding bodies. This discussion went so far as to say, that while less prevalent diseases (or lesser known) or certain minority groups of people were fascinating, that’s not where the money is at. This is not the first time I’ve had this experience. Continue reading